ライフサイエンスコーパス: Hispanic

1 were black, 37.6% were white, and 16.3% were Hispanic.

2 and 75.1% (n = 151) self-identifying as non-Hispanic.

3 duced DRESS syndrome were African, and 1 was Hispanic.

4 rcent were boys, 78% were white, and 8% were Hispanic.

5 SD), 10) years; 66% were women, and 55% were Hispanic.

6 of participants were white, and 90% were non-Hispanic.

7 0 years, 19% were female, 29% black, and 20% Hispanic.

8 ugh not always significant) for foreign-born Hispanics.

9 s stronger among men, African Americans, and Hispanics.

10 a Natives, and 0.70 (95% CI: 0.60, 0.81) for Hispanics.

11 84% women, 31% non-Hispanic blacks, and 39% Hispanics.

12 as were non-Hispanic black (105 [14.8%]) and Hispanic (1165 [20.0%]) youth compared with non-Hispanic

13 Twenty patients were Hispanic; 13, African; 8, white; and 2, Native American.

14 cans, 21.5 kg/m2 (CI, 18.5 to 24.5 kg/m2) in Hispanics, 20.9 kg/m2 (CI, 19.7 to 22.1 kg/m2) in Chines

15 2%, Chinese American 12.0%, black 24.5%, and Hispanic 21.2%) using biplane and short-axis images.

16 assessed: 2,819 (77%) were white, 553 (15%) Hispanic, 256 (7%) black, and 38 (1%) other.

17 f respondents were non-Hispanic white, 32.3% Hispanic, 27.2% non-Hispanic black, and 7.7% other race/

18 panic white, 13.8% non-Hispanic black, 16.5% Hispanic, 4.0% Asian, and 5.1% other), of whom 474 (5.0%

19 hite, 391 (4.9%) were black, 527 (6.6%) were Hispanic, 424 (5.3%) were Asian/Pacific Islander, 63 (0.

20 nce by ethnicity were 45.5% in Asians, 45.3% Hispanics, 44.20% Blacks, 36.7% Whites, and 14.3% in mix

21 consecutive white (1,107), black (361), and Hispanic (479) older adults who had their first medical-

22 ; mean age, 42.9 years; 87.3% women; and 31% Hispanic, 49% non-Hispanic white, and 20% other race/eth

23 The cohort has 296 decedents: 147 Blacks, 64 Hispanics, 49 Whites, 22 Asians, and 14 mixed ethnicitie

24 ents (55.4%) compared with white (35.5%) and Hispanic (5.8%) patients.

25 e; 4 of white race/ethnicity, 1 Asian, and 1 Hispanic), 5 exhibited an autofluorescent AZOOR line in

26 Most mothers were Hispanic (54%) or black (29%), had a high school educati

27 ce of HLA-B*53 carriage in African (20%) and Hispanic (6%) populations, the probability of all 4 pati

28 Seventeen men (11 Hispanic, 6 white, median age 45 years) were enrolled.

29 ts included 371 women (mean age, 28.1 years; Hispanic, 81.6%; mean weight above prepregnancy weight,

30 65.3% (27654) were white, 12.7% (5365) were Hispanic, 9.4% (3976) were African American, and 12.6% (

31 sepsis hospitalizations), black (94.0), and Hispanic (93.5) patients but remained elevated for Asian

32 We included non-citizen, Hispanic adults aged 19-50 years in our analyses.

33 ational studies have reported that black and Hispanic adults receiving maintenance dialysis survive l

34 ich aims to enroll 1300 individuals (600 non-Hispanic African ancestry, 600 non-Hispanic European anc

35 ided cross-ethnicity replication in the MESA Hispanic-American participants.

36 t in cross-ethnicity analyses among the MESA Hispanic-Americans cohort (OR per triglyceride GRS unit:

37 dividuals of European, African American, and Hispanic ancestry.

38 = 44) of all individuals self-identifying as Hispanic and 75.1% (n = 151) self-identifying as non-His

39 Hispanic and black patients were less likely to enroll a

40 94 women and 8,738 men of European, African, Hispanic and Chinese ancestry, with and without sex stra

41 IV-infected and uninfected women and between Hispanic and non-Hispanic women.

42 nt-rated health for US-born and foreign-born Hispanics and 2) assessed whether neighborhood poverty m

43 ements in the HF hospitalization rates among Hispanics and Asian/Pacific Islanders is needed.

44 Trends highlight increases in women and Hispanics and stable or decreasing representation of non

45 s (white, black, Mexican American, and other Hispanic), and across three Asian subgroups (Chinese, As

46 (26%) were African American, 1823 (15%) were Hispanic, and 1555 (13%) were other races/ethnicities.

47 an, 11 (14%) were white, 16 (21%) were white Hispanic, and 26 (33%) were other/mixed race/ethnicity.

48 ants (52% white, 23% black, 11% Chinese, 14% Hispanic, and 52% men with a mean age of 67.6 years) at

49 n age was 49 years, 76% were white, 12% were Hispanic, and 65% were female.

50 -90.6) in black, 86.0% (95% CI 83.7-88.0) in Hispanic, and 90.7% (95% CI 87.0-93.5) in Asian/Pacific

51 rals produce high SVR rates in white, black, Hispanic, and Asian/Pacific Islander/American Indian/Ala

52 ed in 154 white and 258 nonwhite (ie, Asian, Hispanic, and black) OTRs.

53 ter US study of Caucasian, African-American, Hispanic, and Chinese-American adults aged 45-84 years.

54 small community programs who were White, non-Hispanic, and married (6%).

55 red mortality risk among non-Hispanic black, Hispanic, and non-Hispanic white children who started RR

56 o statins and with drug molecules for black, Hispanic, and non-Hispanic white people, and men and wom

57 s use of IPBR among white, African American, Hispanic, and other minority groups before and after the

58 hinese Americans, 334 African Americans, 252 Hispanics, and 195 South Asians), the prevalence of MAN

59 ethnicities, 10.2% Whites, 4.5% Asians, 3.1% Hispanics, and 2% Blacks; 7.7% children, 7.3% in adults,

60 can Americans, 38.5% (CI, 32.6% to 44.6%) in Hispanics, and 43.6% (CI, 36.8% to 50.6%) in South Asian

61 It is more prevalent among blacks, Hispanics, and Asians compared with whites.

62 cohort included non-Hispanic whites, blacks, Hispanics, and Asians.

63 ach of 4 race/ethnic groups (blacks, Asians, Hispanics, and non-Hispanic whites) were targeted for re

64 ach racial/ethnic group (non-Hispanic black, Hispanic, Asian American and Pacific Islander, and separ

65 American (beta=-2.6 mL/m(2), P<0.0001), and Hispanic (beta=1.1 mL/m(2), P<0.05) ethnicities were ass

66 receive medications (P < .001), as were non-Hispanic black (105 [14.8%]) and Hispanic (1165 [20.0%])

67 eons and the American Cancer Society, on non-Hispanic black (black) and non-Hispanic white (white) pa

68 Interaction terms for non-Hispanic black and Hispanic groups compared with the non

69 morbidity and readmission trends between non-Hispanic Black and White patients for the majority of di

70 te abolished the higher risk of death in non-Hispanic black children (hazard ratio, 0.99; 95% CI, 0.8

71 Non-Hispanic black children and adolescents had a consistent

72 Non-Hispanic black children had higher mortality than non-Hi

73 reduce disparities in mortality risk of non-Hispanic black children treated with RRT.

74 females exist, with Mexican American and non-Hispanic black females at greater risk of ID than non-Hi

75 birth (PTB) prevalence between births of non-Hispanic black individuals and births of non-Hispanic wh

76 erse birth outcomes for infants borne by non-Hispanic black mothers and white mothers.

77 the exception of declines among men and non-Hispanic black patients aged 45 to 54 with subarachnoid

78 Residence in urban or poor areas and non-Hispanic black race/ethnicity were all independently ass

79 ] years; 60.7% non-Hispanic white, 13.8% non-Hispanic black, 16.5% Hispanic, 4.0% Asian, and 5.1% oth

80 ces and ethnicities (non-Hispanic white, non-Hispanic Black, American Indian, Asian Indian, Chinese,

81 Approximately 25% of children were non-Hispanic black, and 26% of children were of Hispanic eth

82 on-Hispanic white, 32.3% Hispanic, 27.2% non-Hispanic black, and 7.7% other race/ethnicity.

83 We compared mortality risk among non-Hispanic black, Hispanic, and non-Hispanic white childre

84 0 and 2013 for each racial/ethnic group (non-Hispanic black, Hispanic, Asian American and Pacific Isl

85 and race/ethnicity (non-Hispanic white, non-Hispanic black, Mexican American), and covariate-adjuste

86 ss effective in preventing CVD deaths in non-Hispanic blacks than in whites.

87 ic whites, 1.67 (95% CI: 1.20, 2.34) for non-Hispanic blacks, 1.57 (95% CI: 1.17, 2.09) for Asians/Pa

88 The sample had 84% women, 31% non-Hispanic blacks, and 39% Hispanics.

89 ALL was negatively associated with SEP among Hispanics but was positively associated among children o

90 tibility and onset age in 65 independent non-Hispanic Caucasian males in the Collaborative Study on t

91 ymptoms of depression and anxiety in 448 non-Hispanic Caucasian university students.

92 Participants included 808 non-Hispanic Caucasian, African American, and Asian universi

93 ng black non-Hispanic children and white non-Hispanic children (80.7%); however, Hispanic children we

94 me direction in CAMP white children and CAMP Hispanic children (combined interaction P = .0065 for re

95 uate the finding of a lower risk of death in Hispanic children (hazard ratio, 0.59; 95% CI, 0.51 to 0

96 ed identical screening rates among black non-Hispanic children and white non-Hispanic children (80.7%

97 In conclusion, Hispanic children had lower mortality than non-Hispanic

98 Hispanic children were less likely than non-Hispanic children to report vision screening (69.8%).

99 hite non-Hispanic children (80.7%); however, Hispanic children were less likely than non-Hispanic chi

100 r for childhood ALL and is more prominent in Hispanic children.

101 were associated with total IgE levels among Hispanic children.

102 ed 22 rs12252_C homozygotes in 185 white non-Hispanic children.

103 in WBCs and total IgE levels in 2 studies of Hispanic children: the Puerto Rico Genetics of Asthma an

104 (mean age: 45 y, range: 18 to 76 y) from the Hispanic Community Health Study / Study of Latinos.

105 mple of Hispanics/Latinos ascertained by the Hispanic Community Health Study and Study of Latinos (HC

106 six Hispanic/Latino background groups in the Hispanic Community Health Study/Study of Latinos (HCHS/S

107 ipants (769 cases, 9,384 controls) of the US Hispanic Community Health Study/Study of Latinos (HCHS/S

108 Admixture mapping analysis of 12,212 Hispanic Community Health Study/Study of Latinos partici

109 The HCHS/SOL (Hispanic Community Health Study/Study of Latinos) recrui

110 udied 12 083 participants from the HCHS/SOL (Hispanic Community Health Study/Study of Latinos), a pop

111 (BP) traits in 12,278 participants from the Hispanics Community Health Study/Study of Latinos (HCHS/

112 detrimental effect on the health of US-born Hispanics, comparable to findings for blacks and black-w

113 her HEI and lower EC scores were observed in Hispanic compared with white participants.

114 duals of European, South Asian, African, and Hispanic descent (pan-ancestry, approximately 475 000),

115 related NHW patients, variants present in 19 Hispanic EOAD WES families, and genes with variants in m

116 white race (56.9%) with black race (16.7%), Hispanic ethnicity (15.8%), and Asian race (2.8%) compri

117 Hispanic ethnicity (OR: 1.8; P < 0.001) and African Amer

118 relative risk = 1.10; 95% CI, 1.04-1.16) and Hispanic ethnicity (relative risk = 1.08; 95% CI, 1.02-1

119 African-American race/Hispanic ethnicity and requirement for more than 1 antih

120 Black race and Hispanic ethnicity are independently associated with mor

121 for baseline characteristics, black race and Hispanic ethnicity remain independent predictors of trea

122 icantly associated with HO-MRSA BSIs whereas Hispanic ethnicity was negatively associated (rate ratio

123 Black race and Hispanic ethnicity were associated with lower rates of s

124 perimenopause persisted after adjustment for Hispanic ethnicity, antiretroviral use, and alcohol (0.1

125 Hispanic ethnicity, bonded release, and psychiatric como

126 ting for individual age, sex, nonwhite race, Hispanic ethnicity, education, and marital status, as we

127 Among the entire cohort, Hispanic ethnicity, male sex, VAT, and HOMA-IR were inde

128 reased frequency of Ph-like ALL in adults of Hispanic ethnicity, significantly inferior outcomes of a

129 porting black race, and 505 (6.7%) reporting Hispanic ethnicity.

130 -Hispanic black, and 26% of children were of Hispanic ethnicity.

131 percent of patients with Ph-like ALL were of Hispanic ethnicity.

132 ican American women are more likely than non-Hispanic European American women to be obese and to be d

133 (600 non-Hispanic African ancestry, 600 non-Hispanic European ancestry, and 100 Hispanic) who meet r

134 od, all 3 racial groups (whites, blacks, and Hispanics) experienced substantial increase in hypertens

135 Among Hispanics, FFIs declined (change = -0.28; Ptrend < 0.000

136 te (from 21.1 % in 2009 to 9.4% in 2015) and Hispanic (from 8.2% in 2009 to 4.7% in 2015) students ov

137 Interaction terms for non-Hispanic black and Hispanic groups compared with the non-Hispanic white gro

138 ion was observed among ethnic groups (Blacks>Hispanics>Whites).

139 In the univariable analysis, Hispanics had higher odds of adherence to any AET at ini

140 Blacks and Hispanics had similar mortality rates compared with whit

141 Rates in Hispanics have surpassed those in Asian Americans.

142 l segregation, come into play in determining Hispanic health for the US-born in a way that does not o

143 nderstanding the fundamental determinants of Hispanic health, few studies have investigated how metro

144 whites, blacks, Mexican Americans, and other Hispanics in the United States.

145 A threshold pattern was observed among Hispanics, in that lower mortality risk was found for al

146 were significantly associated with black non-Hispanic (incidence rate ratio [IRR], 1.29; 95% CI, 1.17

147 eased substantially across all age groups in Hispanic individuals (up to 3.2% per year), black indivi

148 ting in an estimated 112 000 fewer deaths in Hispanic individuals, 311 000 fewer deaths in black indi

149 tributed to declining premature mortality in Hispanic individuals, black individuals, and Asians and

150 articularly large among African American and Hispanic individuals.

151 ratio [IRR], 1.29; 95% CI, 1.17 to 1.42) and Hispanic (IRR, 1.11; 95% CI, 1.03 to 1.20) race/ethnicit

152 udy of Latinos), a population-based study of Hispanic/Latino adults 18 to 74 years of age.

153 r with glycemic biomarkers in a cohort of US Hispanic/Latino adults.

154 Hispanic/Latino Americans are a diverse and understudied

155 values for FVC and FEV1 than those in other Hispanic/Latino background groups and also than Mexican

156 subjects and 5,247 control subjects from six Hispanic/Latino background groups in the Hispanic Commun

157 lop spirometry reference equations for adult Hispanic/Latino background groups in the United States.

158 /Latinos, but whether associations differ by Hispanic/Latino background remains unknown.

159 deled as a function of sex, age, height, and Hispanic/Latino background to produce background-specifi

160 nics/Latinos, but allele frequency varies by Hispanic/Latino background/ancestry.

161 or Mexican Americans but not for others with Hispanic/Latino backgrounds.

162 e association study of melanin levels in 285 Hispanic/Latino individuals from Puerto Rico, analyzing

163 Studies have shown that Hispanic/Latino people have poor eye care utilization, b

164 Among Hispanic/Latino people, age, educational level, income,

165 ter exposure to eye health information among Hispanic/Latino people.

166 albumin excretion and Amerindian ancestry in Hispanic/Latino populations.

167 0(-35) for drinks/week), which replicated in Hispanic/Latinos (OR=0.72, P=4.35 x 10(-7) and beta=-0.2

168 race/ethnicity groups: non-Hispanic whites, Hispanic/Latinos, East Asians and African Americans.

169 a stronger predictor of incident obesity in Hispanics/Latinos (OR = 1.97, 95% CI: 1.73, 2.24; P < 0.

170 opulation-based probability sample of 16,415 Hispanics/Latinos aged 18-74 years living in the Bronx,

171 netic factors underlying basal WBC traits in Hispanics/Latinos are unknown.

172 , ethnically diverse US population sample of Hispanics/Latinos ascertained by the Hispanic Community

173 ly high risk of weight gain and obesity, and Hispanics/Latinos may be especially vulnerable to the ob

174 2 diabetes (T2D) have been conducted in U.S Hispanics/Latinos of diverse backgrounds who are disprop

175 rican-specific alleles associate with CKD in Hispanics/Latinos, but allele frequency varies by Hispan

176 ancestry alleles may contribute to CKD among Hispanics/Latinos, but whether associations differ by Hi

177 f CP among a large community-based sample of Hispanics/Latinos.

178 the variation of urine albumin excretion in Hispanics/Latinos.

179 n, African, and Asian ancestry generalize to Hispanics/Latinos.

180 n American (OR, 5.17; 95% CI, 3.16-8.45) and Hispanic males (OR, 2.58; 95% CI, 1.56-4.26).

181 n American (OR, 2.82; 95% CI, 1.77-4.50) and Hispanic males (OR, 2.91; 95% CI, 1.75-4.82), and 2 to 5

182 that the current aggregate classification of Hispanics masks heterogeneity in CVD mortality reporting

183 12% of patients were female, 36% black, 13% Hispanic; median age was 37 years, CD4 count 321 cells/m

184 ack women (HR, 0.81, 95% CI, 0.67-0.98), and Hispanic men (HR, 0.61, 95% CI, 0.42-0.89) and women (HR

185 Hispanic men had a rate that was 32% greater in 2002 and

186 vey, we 1) examined the relationship between Hispanic metropolitan segregation and respondent-rated h

187 For Hispanics, moderate and high levels of social integratio

188 252), 33.3% were black (n = 240), 21.8% were Hispanic (n = 157), and 9.9% were of another race/ethnic

189 rquartile range, 1-12 years), one-third were Hispanic (n = 28 [34%]), and two-thirds (n = 55 [67%]) w

190 4,201), non-Hispanic White (n = 20,217) and Hispanic (n = 5,097) groups.

191 The findings of a reverse association in Hispanics need to be confirmed and further explained in

192 0.59 [95% CI, 0.36-0.94] for uninsured) and Hispanics (odds ratio, 0.74 [95% CI, 0.60-0.91] for insu

193 the overreporter phenotype: non-white race: Hispanic, odds ratio (OR), 2.4, P = .02; Asian, OR, 3.1,

194 ere white, 151 (42%) were black, 8 (2%) were Hispanic or Latino, 9 (2.5%) were of other race/ethnicit

195 black or African American and 243 (18.3%) as Hispanic or Latino.

196 [OR], 0.66; 95% CI, 0.50 to 0.88; P = .004; Hispanic OR, 0.76; 95% CI, 0.61 to 0.94; P = .01).

197 he association was no longer significant for Hispanics (OR, 0.95; 95% CI, 0.78 to 1.17) or blacks (OR

198 Risk was more pronounced in Hispanics (OR=5.90, CI=1.89-25.96) than in non-Hispanic

199 rval (CI) 2.9-3.5); less likely to be Black, Hispanic, or Asian versus White/non-Hispanic (ORadj's =

200 e Black, Hispanic, or Asian versus White/non-Hispanic (ORadj's = 0.4-0.6, p < 0.01); more likely to b

201 in whole blood of 573 individuals of diverse Hispanic origin who also had high-density genotype data.

202 ntinue to be emphasized in white, Asian, and Hispanic OTRs.

203 years), race (lower in African American and Hispanic participants), geographic location (lower in We

204 Among African American and Hispanic participants, adjusted risk differences compari

205 Hispanic patients were more likely to be admitted to an

206 African American patients, Hispanic patients, and new high-intensity statin users w

207 actor in all cancers, but only for black and Hispanic patients.

208 opulation comprised 48 white, 9 Asian, and 3 Hispanic patients.

209 46.8 per 100 person-years), Black and Latino/Hispanic people (41.8 and 39.5 per 100 person-years, res

210 All participants were white, non-Hispanic persons 18 years or older who had had at least

211 comes, approximately 1 in 5 black and 1 in 3 Hispanic persons with a chronic disease continued to lac

212 ses in acquisitions occurred among white and Hispanic persons, but not among black persons, and among

213 wide range of experiences within the diverse Hispanic population and suggests that socioeconomic stat

214 d with other mental disorders, especially in Hispanic populations.

215 Hispanic race, Asian race, Medicaid insurance, and no in

216 readmissions included age, female sex, black/Hispanic race, prior amputation, Charlson comorbidity in

217 stage (III), younger age (<40 yrs), Black or Hispanic race/ethnicity versus non-Hispanic White (OR 1.

218 ges over time were found among the 3 largest Hispanic subgroups in the United States.

219 Deaths from CVD for the 3 largest US Hispanic subgroups-Mexicans, Puerto Ricans, and Cubans-c

220 onal CVD mortality data for the 3 largest US Hispanic subgroups.

221 By 2012, rates in Hispanics surpassed those in Asians, and rates in Texas

222 n the population is more common in black and Hispanic than in white individuals and is associated wit

223 he annual rate of increase was greater among Hispanics than among non-Hispanic whites (4.2% vs. 1.2%,

224 med; this proportion was higher among blacks/Hispanics than others (48% v 33%; P = .02).

225 d stable or decreasing representation of non-Hispanic underrepresented minority critical care fellows

226 3 PUFAs with nonfatal MI risk in Costa Rican Hispanics.We analyzed cross-sectional data from 1932 cas

227 ved more intensive antihypertensive therapy, Hispanics were undertreated.

228 panic (1165 [20.0%]) youth compared with non-Hispanic white (17119 [23.1%]) youth (P < .001).

229 n [SD] age, 31.0 [5.7] years), most were non-Hispanic white (1957 [73.7%]), 98 had panic disorder, 25

230 009 to 10.6 % in 2015) students overall, non-Hispanic white (from 21.1 % in 2009 to 9.4% in 2015) and

231 entative sample of US Black (n = 4,201), non-Hispanic White (n = 20,217) and Hispanic (n = 5,097) gro

232 ent were women (n = 17659), and 69% were non-Hispanic white (n = 20842).

233 hnic Cohort study who self-identified as non-Hispanic White (n = 32,103), African American (n = 30,20

234 cific mortality among AIAN (n = 582) and non-Hispanic white (NHW; n = 82,696) enrollees of Kaiser Per

235 Black or Hispanic race/ethnicity versus non-Hispanic White (OR 1.10, 95% confidence interval (CI) 1.

236 ciety, on non-Hispanic black (black) and non-Hispanic white (white) patients, 18-64 years old, diagno

237 y fat levels more accurately than BMI in non-Hispanic white adolescents aged 8 to 17 years.

238 th Interview Survey data including 10262 non-Hispanic white adults aged 18 to 60 years without a hist

239 Data were analyzed from 8,588 non-Hispanic white adults in the Health and Retirement Study

240 ic Obstructive Pulmonary Disease [COPD]; non-Hispanic white and African American), ECLIPSE (Evaluatio

241 econd most VI is projected to shift from non-Hispanic white children (26.3% in 2015 decreasing to 16.

242 among non-Hispanic black, Hispanic, and non-Hispanic white children who started RRT between 1995 and

243 black children had higher mortality than non-Hispanic white children, which was related to difference

244 spanic children had lower mortality than non-Hispanic white children.

245 maintenance dialysis survive longer than non-Hispanic white counterparts.

246 lace among certain subgroups, especially non-Hispanic white female students.

247 black females at greater risk of ID than non-Hispanic white females.

248 ck and Hispanic groups compared with the non-Hispanic white group were not statistically significant.

249 Hispanic black individuals and births of non-Hispanic white individuals in California, according to i

250 and obstruction was demonstrated in all non-Hispanic white individuals in the Pittsburgh Specialized

251 Among males, non-Hispanic white individuals were significantly more likel

252 Non-Hispanic white individuals with clinical diagnostic and

253 Average birthweight of non-Hispanic white infants was 3381 g, while for other races

254 For example, 12 years after detention, non-Hispanic white males had nearly 3 times the odds of educ

255 Participants included 2285 non-Hispanic white participants aged 8 to 29 years.

256 d 90 [52.3%] in the stent group; and 114 non-Hispanic white patients [65.9%] in the stoma group and 9

257 drug molecules for black, Hispanic, and non-Hispanic white people, and men and women of Asian, Nativ

258 is, male sex, African-American race, and non-Hispanic white race/ethnicity were significantly associa

259 SD] age, 61.6 [11.0] years; 1071 [56.3%] non-Hispanic white) saw any medical oncologist.

260 [interquartile range, 9.0] years; 60.7% non-Hispanic white, 13.8% non-Hispanic black, 16.5% Hispanic

261 5.8 years) and 32.8% of respondents were non-Hispanic white, 32.3% Hispanic, 27.2% non-Hispanic black

262 ears; 87.3% women; and 31% Hispanic, 49% non-Hispanic white, and 20% other race/ethnicity) were rando

263 ferences among 14 races and ethnicities (non-Hispanic white, non-Hispanic Black, American Indian, Asi

264 eir sum by age, sex, and race/ethnicity (non-Hispanic white, non-Hispanic black, Mexican American), a

265 Although the majority were non-Hispanic white, well educated, and economically well off

266 Participants were 67% male, 84% non-Hispanic white, with mean age+/-SD 62+/-11 years; 16% (n

267 All participants self-identified as non-Hispanic white.

268 (65.8%) were male and 17119 (82.2%) were non-Hispanic white.

269 years, 51.8% were female, and 56.6% were non-Hispanic white.

270 also enrolled (race/ethnicity other than non-Hispanic white: 16%; no college degree: 35%; household i

271 ildren (median age, 22 months; 55% male; 61% Hispanic white; 40 per group), 59 completed the trial (2

272 ears; participants were 55% male and 66% non-Hispanic white; 59% had leukemia/lymphoma.

273 e was greater among Hispanics than among non-Hispanic whites (4.2% vs. 1.2%, P<0.001).

274 higher in Asians/Pacific Islanders than non-Hispanic whites (aIRR = 2.09); after induction immunosup

275 , 95% CI: 1.73, 2.24; P < 0.001) than in non-Hispanic whites (OR = 1.54, 95% CI: 1.25, 1.91; P < 0.00

276 spanics (OR=5.90, CI=1.89-25.96) than in non-Hispanic whites (OR=2.10 CI= 0.69-7.13).

277 The adenocarcinoma rate rose among non-Hispanic whites and among black men.

278 a genome-wide significant association in non-Hispanic whites between the previously reported SNP rs12

279 Our prior assessment in California non-Hispanic whites showed substantial increases in invasive

280 2259 participants randomized, 1702 were non-Hispanic whites who completed the trial and had genotype

281 c groups (blacks, Asians, Hispanics, and non-Hispanic whites) were targeted for recruitment.

282 onfidence interval (CI): 1.15, 1.44) for non-Hispanic whites, 1.67 (95% CI: 1.20, 2.34) for non-Hispa

283 The cohort included non-Hispanic whites, blacks, Hispanics, and Asians.

284 ) cohort, in four race/ethnicity groups: non-Hispanic whites, Hispanic/Latinos, East Asians and Afric

285 ageal adenocarcinoma is more frequent in non-Hispanic whites, whereas esophageal squamous cell carcin

286 e, Japanese, and Filipino) compared with non-Hispanic whites.

287 .27; 95% CI, 1.04 to 1.54) compared with non-Hispanic whites.

288 nd pulse pressure, respectively, in GERA non-Hispanic whites.

289 600 non-Hispanic European ancestry, and 100 Hispanic) who meet rigorous clinical criteria for idiopa

290 4 white, 8 African American, 25 Asian, and 3 Hispanic) with a mean (SD) age of 51.8 (15.9) years (26

291 white, 23 African American, 8 Asian, and 11 Hispanic) with a mean (SD) age of 53.6 (16.2) years (27

292 Among the 230 participants, 152 (66.1%) were Hispanic, with a mean (SD) age of 31.4 (7.3) years.

293 ction was significantly more prevalent among Hispanic women (1.6% vs. 0.2%; p < 0.001).

294 ly specific risk reduction interventions for Hispanic women should focus on awareness of partner risk

295 03 to 2012 ranged from 85 per 100000 for all Hispanic women to 144 per 100000 for Cuban men, but rate

296 Hispanic women were more likely than other women to be d

297 For Hispanic women, the rate was 55% greater in 2002 and nar

298 ninfected women and between Hispanic and non-Hispanic women.

299 th higher metabolic syndrome among black and Hispanic young adults from disadvantaged childhood envir

300 Ethnicity moderated outcomes, with Hispanic youth having substantially stronger response to